Silent coronary artery disease (CAD) is one of the manifestations of heart disease that particularly affects subjects with type 2 diabetes mellitus (T2DM). From a clinical point of view, silent CAD represents a constant challenge for the diabetologist, who has to decide whether a patient could or could not be screened for this disease. In the present narrative review, several aspects of silent CAD are considered: the epidemiology of the disease, the associated risk factors, and main studies conducted, in the last 20 years, especially aimed to demonstrate the usefulness of the screening of silent CAD, to improve cardiovascular outcomes in type 2 diabetes
PurposeThe aim of this work was to examine the relation between the severity of silent ischemic epis...
OBJECTIVES: The purpose of this study was to evaluate prevalence, progression, treatment, and outcom...
diabetes mellitus is a coronary artery disease (CAD) [5,6], these observations have raised the quest...
The prevalence of obesity and diabetes is increasing rapidly. Coronary artery disease (CAD) represen...
International audienceAims: To assess the evolution of silent myocardial ischaemia prevalence and of...
PubMedID: 14740277The purpose of this study was to estimate the prevalence and risk factors of silen...
AIMS: The cost-effectiveness of screening for silent coronary heart disease (CHD) in type 2 diabete...
SummaryBackgroundScreening for silent myocardial ischaemia (SMI) is a controversial strategy undergo...
Aims: The cost-effectiveness of screening for silent coronary heart disease (CHD) in type 2 diabetes...
Introduction: Atherosclerotic cardiovascular disease is a significant modifiable complication in pa...
Clinical research. Presentation Type: Oral presentation. Introduction: In patients with type 2 diabe...
OBJECTIVE—To evaluate if silent myocardial ischemia (SMI) and silent coronary artery dis-ease (CAD) ...
The aim of this work was to examine the relation between the severity of silent ischemic episodes de...
Objective Despite the association of diabetes mellitus type 2 (DM2) with silent myocardial ischaemia...
OBJECTIVE: To find the frequency of silent myocardial ischaemia in diabetics as compared to non-diab...
PurposeThe aim of this work was to examine the relation between the severity of silent ischemic epis...
OBJECTIVES: The purpose of this study was to evaluate prevalence, progression, treatment, and outcom...
diabetes mellitus is a coronary artery disease (CAD) [5,6], these observations have raised the quest...
The prevalence of obesity and diabetes is increasing rapidly. Coronary artery disease (CAD) represen...
International audienceAims: To assess the evolution of silent myocardial ischaemia prevalence and of...
PubMedID: 14740277The purpose of this study was to estimate the prevalence and risk factors of silen...
AIMS: The cost-effectiveness of screening for silent coronary heart disease (CHD) in type 2 diabete...
SummaryBackgroundScreening for silent myocardial ischaemia (SMI) is a controversial strategy undergo...
Aims: The cost-effectiveness of screening for silent coronary heart disease (CHD) in type 2 diabetes...
Introduction: Atherosclerotic cardiovascular disease is a significant modifiable complication in pa...
Clinical research. Presentation Type: Oral presentation. Introduction: In patients with type 2 diabe...
OBJECTIVE—To evaluate if silent myocardial ischemia (SMI) and silent coronary artery dis-ease (CAD) ...
The aim of this work was to examine the relation between the severity of silent ischemic episodes de...
Objective Despite the association of diabetes mellitus type 2 (DM2) with silent myocardial ischaemia...
OBJECTIVE: To find the frequency of silent myocardial ischaemia in diabetics as compared to non-diab...
PurposeThe aim of this work was to examine the relation between the severity of silent ischemic epis...
OBJECTIVES: The purpose of this study was to evaluate prevalence, progression, treatment, and outcom...
diabetes mellitus is a coronary artery disease (CAD) [5,6], these observations have raised the quest...